Literature DB >> 14564335

Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds--the TEMISTOCLE study.

Andrea Di Lenarda1, Marino Scherillo, Aldo Pietro Maggioni, Nicola Acquarone, Giovanni Battista Ambrosio, Massimo Annicchiarico, Paolo Bellis, Paolo Bellotti, Renata De Maria, Rinaldo Lavecchia, Donata Lucci, Giovanni Mathieu, Cristina Opasich, Maurizio Porcu, Luigi Tavazzi, Massimo Cafiero.   

Abstract

BACKGROUND: The purpose pf the current article is to describe the clinical profile, use of resources, management and outcome in a population of real-world inpatients with heart failure. METHODS AND
RESULTS: With a prospective, cross-sectional survey on acute hospital admissions, we evaluated the overall and provider-related differences in patient characteristics, diagnostic work-up, treatment and inhospital outcome of 2127 patients with heart failure admitted to 167 cardiology departments and 250 internal medicine departments between February 14 and 25, 2000. Patients admitted to cardiology units were younger (56.3% >70 years vs 76.2%, P <.0001), had more severe symptoms (NYHA IV 35% vs 29%, P =.00014), and more often underwent evaluation of ventricular function (89.3% vs 54.8%, P <.0001) and coronary angiography (7.5% vs 0.9%, P <.0001) than those admitted to medical units. Moreover, they were more often prescribed beta-blockers (17.8% vs 8.7%, P <.0001). However, prescription of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers (78.7% vs 81.5%, P = not significant [NS]) and inhospital mortality (5.2% vs 5.9%, P = NS) were similar. A 6-month follow-up visit was performed in 56.4% of cases (68.2% of cardiology vs 49.4% of medicine patients, P <.0001); 6-month readmission (43.7% vs 45.4%, P = NS) and mortality (13.9% vs 16.7%, P = NS) rates were similar.
CONCLUSIONS: Patients with heart failure admitted to cardiology and internal medicine units represent 2 clearly different populations. In both groups, diagnostic procedures and evidence-based treatments, such as beta-blockers, appeared to be underused, and there was a lack of structured follow-up, as well as a poor 6-month prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564335     DOI: 10.1016/S0002-8703(03)00315-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  19 in total

1.  In-hospital management of heart failure: in 10 years we have improved, but not enough.

Authors:  Sonia Ferretto; Chiara Dalla Valle; Sonia Cukon Buttignoni; Luca Brugnaro; Giovanni Maria Boffa
Journal:  Intern Emerg Med       Date:  2010-12-09       Impact factor: 3.397

Review 2.  Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure.

Authors:  Carlo Rostagno; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2008-02-26       Impact factor: 3.397

Review 3.  The Stress-Response MAP Kinase Signaling in Cardiac Arrhythmias.

Authors:  Xun Ai; Jiajie Yan; Elena Carrillo; Wenmao Ding
Journal:  Rev Physiol Biochem Pharmacol       Date:  2016       Impact factor: 5.545

4.  Long-term management of chronic heart failure patients in internal medicine.

Authors:  Anna Belfiore; Vincenzo Ostilio Palmieri; Carla Di Gennaro; Enrica Settimo; Maria Grazia De Sario; Stefania Lattanzio; Margherita Fanelli; Piero Portincasa
Journal:  Intern Emerg Med       Date:  2019-01-18       Impact factor: 3.397

5.  Early and personalized ambulatory follow-up to tailor furosemide and fluid intake according to congestion in post-discharge heart failure.

Authors:  Gaspare Parrinello; Daniele Torres; Salvatore Paterna; Pietro Di Pasquale; Caterina Trapanese; Mauro Cardillo; Michele Bellanca; Sergio Fasullo; Giuseppe Licata
Journal:  Intern Emerg Med       Date:  2011-05-19       Impact factor: 3.397

6.  Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice.

Authors:  Giorgio Costantino; Anna Maria Rusconi; Pier Giorgio Duca; Stefano Guzzetti; Ilaria Bossi; Marta Del Medico; Giuseppina Pisano; Mara Bulgheroni; Monica Solbiati; Raffaello Furlan; Nicola Montano
Journal:  Intern Emerg Med       Date:  2008-08-09       Impact factor: 3.397

Review 7.  Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology.

Authors:  Nathaniel Mark Hawkins; Mark C Petrie; Pardeep S Jhund; George W Chalmers; Francis G Dunn; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

Review 8.  SR calcium handling dysfunction, stress-response signaling pathways, and atrial fibrillation.

Authors:  Xun Ai
Journal:  Front Physiol       Date:  2015-02-19       Impact factor: 4.566

9.  Acute heart failure in the elderly: setting related differences in clinical features and management.

Authors:  Francesco Orso; Alessandra Pratesi; Andrea Herbst; Anna Chiara Baroncini; Francesca Bacci; Gabriele Ciuti; Andrea Berni; Camilla Tozzetti; Carlo Nozzoli; Alberto Moggi Pignone; Loredana Poggesi; Luciano Gabbani; Mauro Di Bari; Francesco Fattirolli; Massimo Milli; Andrea Ungar; Niccolò Marchionni; Samuele Baldasseroni
Journal:  J Geriatr Cardiol       Date:  2021-06-28       Impact factor: 3.327

10.  Prognostic factors of mid-term clinical outcome in congestive heart failure patients discharged after acute decompensation.

Authors:  Mauro Feola; Enrico Lombardo; Marzia Testa; Enrico Avogadri; Salvatore Piccolo; Antonello Vado
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.